Jpmorgan Chase & CO Silk Road Medical Inc Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Silk Road Medical Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 34,869 shares of SILK stock, worth $958,548. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,869
Previous 34,270
1.75%
Holding current value
$958,548
Previous $627,000
50.24%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SILK
# of Institutions
154Shares Held
36.7MCall Options Held
148KPut Options Held
205K-
Black Rock Inc. New York, NY3.37MShares$92.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.97MShares$81.6 Million0.0% of portfolio
-
Magnetar Financial LLC Evanston, IL1.97MShares$54.2 Million1.37% of portfolio
-
Fil LTD Hamilton, D01.58MShares$43.4 Million0.04% of portfolio
-
Bamco Inc New York, NY1.28MShares$35.2 Million0.1% of portfolio
About Silk Road Medical Inc
- Ticker SILK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,565,600
- Market Cap $1.03B
- Description
- Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...